# Use of Hyaluronic Acid as a Therapeutic Strategy for Bone Repair in Human

> **NCT02709525** · PHASE1,PHASE2 · COMPLETED · sponsor: **Federal University of Minas Gerais** · enrollment: 16 (actual)

## Conditions studied

- Alveolar Bone Loss

## Interventions

- **DRUG:** hyaluronic acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02709525
- **Lead sponsor:** Federal University of Minas Gerais
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-07
- **Final completion:** 2016-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709525, "Use of Hyaluronic Acid as a Therapeutic Strategy for Bone Repair in Human". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02709525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*